Skip to main content

Advertisement

SpringerLink
Log in

Evaluation of immunohistochemical expression of survivin and its correlation with −31G/C gene polymorphism in colorectal cancer

  • Original Paper
  • Published:
Medical Molecular Morphology Aims and scope Submit manuscript

Abstract

Colorectal cancer (CRC) placed among the most common neoplasm. Survivin is a member of the inhibitor apoptosis gene family. This gene could be associated with aggressive behavior in numerous types of cancers. The aim of the present study was to evaluate the immunohistochemical expression of survivin gene and its correlation with −31G/C polymorphism in CRC patients. This case–control study was performed on 90 cases: 30 adenocarcinoma, 30 adenomatous polyp, and 30 normal colon. Immunohistochemical expression of survivin evaluated on formalin-fixed paraffin-embedded tissue and −31G/C polymorphism was analyzed by polymerase chain reaction-restriction fragment length polymorphism analysis. Results showed that the subjects carrying C/C genotype with 43.3% (p = 0.002‚ OR = 12.188, CI = 2.530–58.720) and G/C genotype with 43.3% (p = 0.032‚ OR = 4.432, CI = 1.133–17.341) significantly had increased risk of CRC compared with subjects carrying GG genotype. Allelic frequencies showed statistically significant difference (p = 0.001) among adenocarcinoma (G = 35%, C = 65%), adenomatous (G = 43.3, C = 56.7), and normal group (G = 68.3, C = 31.7). Immunohistological evaluation showed nuclear survivin protein expression in patients with the CC genotype higher than in patient with the GG and GC genotypes (p = 0.002). The results suggest that C allele of − 31G/C polymorphism in survivin might be cooperative in CRC development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Charkhat Gorgich EA, Heidari Z, Mahmoudzadeh- Sagheb H (2017) P16ink4a subcellular expression patterns in colorectal adenocarcinoma, adenoma and non-neoplastic tissue samples. Asian Pac J Cancer Prev 18(11):3049–3054. https://doi.org/10.22034/apjcp.2017.18.11.3049

    Article  PubMed  Google Scholar 

  2. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46(5):645–650

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Jakubowska K, Pryczynicz A, Dymicka-Piekarska V, Famulski W, Guzińska-Ustymowicz K (2016) Immunohistochemical expression and serum level of survivin protein in colorectal cancer patients. Oncol Lett 12(5):3591–3597

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Mahdavinia M, Bishehsari F, Ansari R, Norouzbeigi N, Khaleghinejad A, Hormazdi M, Rakhshani N, Malekzadeh R (2005) Family history of colorectal cancer in Iran. BMC Cancer 5(1):112

    Article  PubMed  PubMed Central  Google Scholar 

  5. Rahimi Pordanjani S, Baeradeh N, Lotfi MH, Pourmohammadi B (2016) Epidemiology of colorectal cancer: incidence, mortality, survival rates and risk factors. Razi J Med Sci 23(144):41–50

    Google Scholar 

  6. Dolatkhah R, Somi MH, Bonyadi MJ, Asvadi Kermani I, Farassati F, Dastgiri S (2015) Colorectal cancer in Iran: molecular epidemiology and screening strategies. J Cancer Epidemiol 2015:643020

    Article  PubMed  PubMed Central  Google Scholar 

  7. Hosseinzadeh A, Daraei A (2012) Environmental factors associated with sporadic colorectal cancer. J Health Syst Res 8:229–236

    Google Scholar 

  8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96

    Article  PubMed  Google Scholar 

  9. Gayet J, Zhou X-P, Duval A, Rolland S, Hoang J-M, Cottu P, Hamelin R (2001) Extensive characterization of genetic alterations in a series of human colorectal cancer cell lines. Oncogene 20(36):5025–5032

    Article  CAS  PubMed  Google Scholar 

  10. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61(2):69–90

    Article  PubMed  Google Scholar 

  11. Montazerhaghighi M, Najjarsadeghi R, Mohebi S, Vahedi M (2009) G1793A genotype of MTHFR gene in patients with sporadic colorectal cancer. Pejouhandeh 3:147–151

    Google Scholar 

  12. Dadkhah A, Fatemi F (2010) Effects of anti tomuric property of black cumin on induced colon cancer with dimethyl hydrazine in rat. New Find Lab Res 2010:1–32

    Google Scholar 

  13. Mahmoudzadeh Sagheb H, Heidari Z, Jahantigh M, Narouei M (2016) Immunohistochemical expression of p53 and Ki-67 genes in gastric cancer and precancerous lesions in the patients with Helicobacter pylori infection. Gene Cell Tissue 3(4):e41341. https://doi.org/10.17795/gct-41341

    Article  Google Scholar 

  14. Liu Y, Li L, Qi H, Gao Y, Liu S, Xu C (2013) Survivin −31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis. PLoS One 8(2):e54081

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Babaei E, Shariat Torbaghan S, Emadi Bayegi M (2006) Detection of survivin gene expression in formalin-fixed paraffin-embedded tissues of human osteosarcoma: its potential usefulness in diagnosis and prognosis of bone tumors. Iran Biomed J 10(1):39–45

    CAS  Google Scholar 

  16. Gayathri C, Rao GV (2017) Immunohistochemical expression of Survivin in oral leukoplakia and oral squamous cell carcinoma. J Dr NTR Univ Health Sci 6(1):39

    Google Scholar 

  17. Antonacopoulou AG, Floratou K, Bravou V, Kottorou A, Dimitrakopoulos F-I, Marousi S, Stavropoulos M, Koutras AK, Scopa CD, Kalofonos HP (2010) The survivin −31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Anal Cell Pathol 33(5–6):177–189

    Article  CAS  Google Scholar 

  18. Kostić M, Nikolić N, Ilić B, Čarkić J, Milenković S, Vukadinović M (2013) Analysis of polymorphism in the survivin gene promoter as a potential risk factor for head and neck cancers development. Srp Arh Celok Lek 141(5–6):304–307

    Article  PubMed  Google Scholar 

  19. Sharief MK, Noori MA, Douglas MR, Semra YK (2002) Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis. Eur J Neurol 9(5):503–510

    Article  CAS  PubMed  Google Scholar 

  20. Shintani M, Sangawa A, Yamao N, Kamoshida S (2013) Immunohistochemical expression of nuclear and cytoplasmic survivin in gastrointestinal carcinoma. Int J Clin Exp Pathol 6(12):2919

    PubMed  PubMed Central  Google Scholar 

  21. Tecleab AG (2013) Regulation of the tumor suppresser p53 and survivin by Ras and Ral GTPases: implications for malignant transformation. University of South Florida, Tampa

    Google Scholar 

  22. Upadhyay R, Khurana R, Kumar S, Ghoshal UC, Mittal B (2011) Role of survivin gene promoter polymorphism (−31G>C) in susceptibility and survival of esophageal cancer in northern India. Ann Surg Oncol 18(3):880–887

    Article  PubMed  Google Scholar 

  23. Dorak MT (2007) Real-time PCR. Taylor and Francis, Routledge

    Book  Google Scholar 

  24. Xu L, Zhou X, Xu L, Yin R (2014) Survivin rs9904341 (G>C) polymorphism contributes to cancer risk: an updated meta-analysis of 26 studies. Tumor Biol 35(2):1661–1669

    Article  CAS  Google Scholar 

  25. Siegel RL, Miller KD, Fedewa SA, Ahnen DJ, Meester RG, Barzi A, Jemal A (2017) Colorectal cancer statistics, 2017. CA Cancer J Clin 67(3):177–193

    Article  PubMed  Google Scholar 

  26. Jaiswal PK, Goel A, Mittal R (2015) Survivin: a molecular biomarker in cancer. Indian J Med Res 141(4):389

    Article  PubMed  PubMed Central  Google Scholar 

  27. Sarela A, Macadam R, Farmery S, Markham A, Guillou P (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46(5):645–650

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Tastekin E, Caloglu VY, Durankus NK, Sut N, Turkkan G, Can N, Puyan FO, Caloglu M (2017) Survivin expression, HPV positivity and microvessel density in oropharyngeal carcinomas and relationship with survival time. Arch Med Sci 13(6):1467

    Article  CAS  PubMed  Google Scholar 

  29. Antonacopoulou AG, Floratou K, Bravou V, Kottorou A, Dimitrakopoulos F-I, Marousi S, Stavropoulos M, Koutras AK, Scopa CD, Kalofonos HP (2011) The survivin −31 snp in human colorectal cancer correlates with survivin splice variant expression and improved overall survival. Cell Oncol 34(4):381–391

    Article  CAS  Google Scholar 

  30. Liu T-C, Hsieh M-J, Wu W-J, Chou Y-E, Chiang W-L, Yang S-F, Su S-C, Tsao TC-Y (2016) Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer. Int J Med Sci 13(12):929

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Yazdani N, Sayahpour FA, Haghpanah V, Amiri P, Shahrabi-Farahani M, Moradi M, Mirmiran A, Khorsandi M-T, Larijani B, Mostaan LV (2012) Survivin gene polymorphism association with papillary thyroid carcinoma. Pathol Res Pract 208(2):100–103

    Article  CAS  PubMed  Google Scholar 

  32. Zahedi P, Aminimoghaddam S, Sayahpour FA, Haghpanah V, Amiri P, Fereidoni F, Mahrampour E, Larijani B, Tavakkoly-Bazzaz J, Amoli MM (2012) Association of survivin gene polymorphism with endometrial cancer. Int J Gynecol Cancer 22(1):35–37

    Article  PubMed  Google Scholar 

  33. Wang YH, Chiou HY, Lin CT, Hsieh HY, Wu CC, Hsu CD, Shen CH (2009) Association between survivin gene promoter −31 C/G polymorphism and urothelial carcinoma risk in Taiwanese population. Urology 73(3):670–674. https://doi.org/10.1016/j.urology.2008.09.048

    Article  PubMed  Google Scholar 

  34. Bogdanovic L, Lazic M, Bogdanovic J, Soldatovic I, Nikolic N, Radunovic M, Radojevic-Skodric S, Milasin J, Basta-Jovanovic G (2017) Polymorphisms of survivin −31 G/C gene are associated with risk of urothelial carcinoma in Serbian population. J BU ON 22(1):270

    Google Scholar 

  35. Hossein Pour Feizi M, Rojhan Nejad M, Pouladi N, Azarfam P, Montazeri V, Halimi M (2012) The study of survivin gene promoter polymorphism (−31G/C) in breast cancer in north west of Iran. SSU J 20(4):420–428

    Google Scholar 

  36. Yamak N, Yaykasli KO, Yilmaz U, Eroz R, Uzunlar AK, Ankarali H, Sahiner C, Baltaci D (2014) Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population. Asian Pac J Cancer Prev 15(20):8963–8967

    Article  PubMed  Google Scholar 

  37. Kawata N, Tsuchiya N, Horikawa Y, Inoue T, Tsuruta H, Maita S, Satoh S, Mitobe Y, Narita S, Habuchi T (2011) Two survivin polymorphisms are cooperatively associated with bladder cancer susceptibility. Int J Cancer 129(8):1872–1880

    Article  CAS  PubMed  Google Scholar 

  38. Negi A, Puri A, Gupta R, Nangia R, Sachdeva A, Mittal M (2015) Comparison of immunohistochemical expression of antiapoptotic protein survivin in normal oral mucosa, oral leukoplakia, and oral squamous cell carcinoma. Pathol Res Int 2015:1–6

    Article  Google Scholar 

  39. Abdelrahman AE, Abdel-Aziz HR, Hegazy AA, Mohamed A-M (2016) Immunohistochemical study of prognostic relevance of nestin and survivin expression in astrocytic glioma. J Interdiscip Histopathol 4(2):34–40

    Article  Google Scholar 

  40. Li Y, Zhou Y, Zheng J, Niu C, Liu B, Wang M, Fang H, Hou C (2015) Downregulation of survivin inhibits proliferation and migration of human gastric carcinoma cells. Int J Clin Exp Pathol 8(2):1731

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by a dissertation grant (M.Sc. thesis of anatomical sciences of AH, No: IR.ZAUMS.REC.1394.53) from the deputy for Research, Zahedan University of Medical Sciences. The authors would like to thank all the subjects who willingly participated in the study.

Author information

Authors and Affiliations

  1. Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, Islamic Republic of Iran

    Zahra Heidari, Hamidreza Mahmoudzadeh Sagheb & Bita Moudi

  2. Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Islamic Republic of Iran

    Zahra Heidari, Hamidreza Mahmoudzadeh Sagheb, Asiyeh Hakimi & Bita Moudi

Authors
  1. Zahra Heidari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hamidreza Mahmoudzadeh Sagheb
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Asiyeh Hakimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bita Moudi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Zahra Heidari, Asiyeh Hakimi, and Bita Moudi—study design, histological tissue processing; microscopy and quantification of the sections; data acquisition; illustrations; manuscript writing. Hamidreza Mahmoudzadeh-Sagheb—participated in the study design and literature review. All authors had read the manuscript, and are in agreement with the content of the manuscript.

Corresponding author

Correspondence to Asiyeh Hakimi.

Ethics declarations

Conflict of interest

The authors declare that there is no conflict of interests to disclose.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Heidari, Z., Sagheb, H.M., Hakimi, A. et al. Evaluation of immunohistochemical expression of survivin and its correlation with −31G/C gene polymorphism in colorectal cancer. Med Mol Morphol 52, 82–89 (2019). https://doi.org/10.1007/s00795-018-0204-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00795-018-0204-0

Keywords

Search

Navigation